Founded in 1999, Ambry Genetics provides clinical genetic diagnostics and genetics software solutions for medical facilities. Please complete the form below and the appropriate Ambry representative will contact you. What companies has Ambry Genetics acquired? Contact Ambry Genetics today. Press release - Market Growth Insight - Direct-to-consumer Genetic Testing Market Share and SWOT Analysis: Myriad Genetics Inc., 23andMe Inc., Invitae, Ambry Genetics - … Your changes will in fact be stored however can be lost at all times. To use all the functions on Chemie.DE please activate JavaScript. Find out how LUMITOS supports you with online marketing. The function "Store search" is only available to registered users. Subscribe to receive future Ambry updates! ALISO VIEJO, Calif., Feb. 25, 2020 /PRNewswire/ -- Ambry Genetics (Ambry), a leading clinical genetic testing lab, announced the publication of a study in Nature Partner Journal Precision Oncology finding that RNA genetic testing, conducted at the same time as DNA testing, identifies more... View contact profiles from Ambry Genetics, Whole Exome Sequencing Market to Reflect Significant Growth During 2020–2027 : BGI, Ambry Genetics, Eurofins Genomics, Etc, Scipher Medicine® and Ambry Genetics® Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market, First Prospective Study Shows +RNAinsight™ Identifies More Patients with Increased Risk for Hereditary Cancer Than DNA-Only Testing. Ambry Genetics’s official website is See Ambry Genetics Corporation's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform. Continuing education credits may be received for many of our webinars, when they are viewed live. Vice President, Bioinformatics and Computatio... Ambry Genetics’s headquarters are in 1 Enterprise, Aliso Viejo, California, 92656, United States, Ambry Genetics’s phone number is (949) 900-5500. Read the full press release at Ambry Genetics supports ongoing clinician education and data sharing, to help promote scientific discoveries that help improve patient management and care. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE. Ambry News from GenomeWeb, your source for the latest Genetics & Genomics news, company information, and business listings. Ambry Genetics's main competitors are: Invitae, Novogene, MedGenome, Genetic Testing Laboratories. Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting, JAMA Oncology Publishes Ambry’s Results Detailing Genes Associations with Hereditary Breast and Ovarian Cancer, Dr. John E. Niederhuber Appointed Chairman of Konica Minolta’s Scientific Advisory Board, Invicro and Ambry Genetics Appoint Dr. Kenneth Bloom as Chief Medical Officer of Advanced Pathology and Genomic Services, Ambry Genetics in Collaboration with Mayo Clinic and NorthShore University HealthSystem Announce Important Research Contributing to Breast Cancer Risk Prediction, Ambry Genetics Launches AmbryScoreTM to Assist Health Care Providers in Determining Lifetime Breast Cancer Risk, Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine, Ambry Appoints Linh H. Le as New Chief Operating Officer, Ambry Names Tom Schoenherr as Chief Commercial Officer, Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium. This service is free of charge and can be cancelled at any time. Ambry Genetics is in the industry of: Medical Testing & Clinical Laboratories, Healthcare. What is Ambry Genetics’s official website? Ambry Genetics has acquired the companies: Minolta, Depth Security, Serians S.A.S., Indicia Limited, The technologies that are used by Ambry Genetics are: IBM SPSS, MATLAB, Microsoft Project, Final Cut Pro, Ambry Genetics's CFO is Michael Martinson, See more information about Ambry Genetics, 1 Enterprise, Aliso Viejo, California, 92656, United States, New York, NY -- (SBWIRE) -- 10/09/2020 -- The report performs a systematic assessment of both the qualitative and quantitative factors of the Whole Exome Sequencing industry, alongside providing details on the market shares of the prominent companies operating in this industry and their financial standings.